ACS 200®

ACS 200®Kills MRSA!

As you know, Methicillin-Resistant Staphylococcus Aureus (MRSA) is becoming a widespread epidemic. Ever increasing numbers of MRSA patients are presenting themselves who respond minimally to antibiotics (both oral and IV).

Like all superbugs, MRSA is the result of decades of excessive and unnecessary antibiotic use.

For many years, antibiotics have been wrongly prescribed for colds, flu and other viral infections that don't respond to antibiotics, as well as for simple bacterial infections that would normally clear on their own. Even when antibiotics are used appropriately, they contribute to the rise of drug-resistant bacteria because antibiotics simply do not destroy every germ they target. Bacteria evolve quickly, so those that survive treatment with one antibiotic rapidly mutate in order to resist others. Some bacteria like MRSA have become resistant to almost every prescription drug available.

A conceptual visualization of the Methicillin-Resistant Staphylococcus Aureus (MRSA) bacteria

Many practitioners have commented that standard CDC protocols are now ineffective against MRSA. If you have not already, you will most likely be presented with an MRSA patient soon. What protocol will you use for the treatment of this virulent staph infection? When exposed to MRSA, what product will you use to prevent your own infection?

For obvious reasons, many of you have been asking how well ACS 200®performs against MRSA. The testing is now complete and we are excited to reveal the data.

Studies show that ACS 200®achieves significant kill against MRSA in less than one minute.This impressive kill time data demonstrates once again the unmatched pathogen killing power of ACS 200®. As ongoing research studies prove, the unparalleled safety and efficacy of ACS 200®make this Silver-based antimicrobial truly unique. Covered by a growing list of over ten patents, there is not another silver product on the market today that compares in performance to Advanced Cellular Silver (ACS) 200®.

Safety and Efficacy:When choosing an antimicrobial product, safety and efficacy are the only two factors that truly matter. ACS 200®provides 200 parts per million of uniquely energized silver molecules that range in size from 0.4 microns down to nanometer, which are suspended in wetter water®; a proprietary micronutrient transport medium that is 43% lower in surface tension, enabling a more rapid penetration through all biological systems. If you have enjoyed any amount of success with another Silver-based product, you will love the patient success you can achieve using ACS 200®. After all, patient success is your success.

Kill Time Study.

Identifying Staph:Staph infections, including MRSA, generally start as small red bumps that resemble pimples, boils or spider bites. These can quickly turn into deep, painful abscesses that require surgical draining. Sometimes the bacteria remain confined to the skin. But they can also burrow deep into the body, causing potentially life-threatening infections in bones, joints, surgical wounds, the bloodstream, heart valves and lungs.Source: The Mayo Clinic

More than 90,000 Americans get potentially deadly infections each yearfrom this drug-resistant staph"superbug,"according to the Centers for Disease Control and Prevention (CDC) in Atlanta, projecting that 1.7 million patients nationwide will get an infection during a hospital stay this year, and that of those, 99,000 (about 270 per day) will die.

No single pathogen protocol will affect your family and patients health in a more positive way in both treatment and prophylaxis that can be achieved using ACS 200®.